NCT06877130

Brief Summary

The purpose of the study is to investigate the effect of aerobic exercise with Blood flow restriction training (BFR) on cardiovascular function and quality of life in hypertensive elderly patients. Hypothesis There will be no significant effect of aerobic exercise with RBF on cardiovascular function and the quality of life in hypertensive elderly patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 2, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 14, 2025

Completed
Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

11 months

First QC Date

March 2, 2025

Last Update Submit

March 10, 2025

Conditions

Keywords

Metabolic Syndrome XBlood Flow Restriction (BFR) Training EffectsCardiovascular Functions in Elderly

Outcome Measures

Primary Outcomes (10)

  • Weight and height measurement

    Weight and height are recorded, and BMI will be calculated according to the formula: BMI = Weight (Kg) / Height (m2)

    Baseline (assessment).

  • Blood pressure monitoring by (Aneroid Sphygmomanometers)

    Aneroid sphygmomanometers were used to obtain a BP reading (Pickering TG et al., 2005). Virtually 100% of the values. From the aneroid-device were within the three-mm-Hg range recommended' by the Association for the Advancement of Medical instrumentation.

    Baseline (assessment), and at 12 weeks post-intervention.

  • Pulse rate by Pulse oximeter

    It is widely used to noninvasively assess arterial oxyhemoglobin saturation (SpO2).

    Baseline (assessment), and at 12 weeks post-intervention.

  • Lipid profile

    All patients will perform laboratory lipid profile before and after the study. The three main blood levels collected to assess for dyslipidemia is (TG, HDL-C, LDL-C and T.G) after fasting for 8-12 hours.

    Baseline (assessment), and at 12 weeks post-intervention.

  • apolipoprotien test

    : test to detect the risk of cardiovascular disease

    Baseline (assessment), and at 12 weeks post-intervention.

  • time up and go test

    A sturdy armchair with a back was placed at the end of a hallway adjacent to where height and weight measures are routinely taken in the process of rooming participants. A piece of tape was placed on the floor 3 m away from the front edge of the chair. Patients were seated in the chair with back against the chair back, arms resting on the armrests, and given general instructions about the task, including walking at a normal rather than a rapid speed. The TUG required patients to stand up out of the chair, walk 3 m, turn around, walk back to the chair, and sit down. Patients were given the following instructions: "stand up on the word 'go,' walk to the tape, turn around, walk back to the chair, and sit down." The timing of the test began at the word "go," and ended when the participant was seated

    Baseline (assessment), and at 12 weeks post-intervention.

  • Fatigue Assessment Scale

    The FAS is a 10-item scale evaluating symptoms of chronic fatigue. In contrast to other similar measures the FAS treats fatigue as a unidimensional construct and does not separate its measurement into different factors. However, in order to ensure that the scale would evaluate all aspects of fatigue, developers chose items to represent both physical and mental symptoms. Each item of the FAS is answered using a five-point scale ranging from 1 ("never") to 5 ("always"). Items 4 and 10 are reverse scored. Total scores can range from 10, indicating the lowest level of fatigue, to 50, denoting the highest.

    Baseline (assessment), and at 12 weeks post-intervention.

  • HeartQoL questionnaire

    According to European Journal of Preventive Cardiology 2016 HeartQoL is a recently developed core health-related quality of life instrument for patients with coronary heart disease. The current study aims to investigate its association with patients' coronary risk profile and to provide reference values for patients with coronary heart disease

    Baseline (assessment), and at 12 weeks post-intervention.

  • The double product (DP)

    consisting of the SBP multiplied by the pulse rate (PR), is an index of myocardial oxygen consumption

    Baseline (assessment), and at 12 weeks post-intervention.

  • Mean Arterial Pressure

    The definition of mean arterial pressure (MAP) is the average arterial pressure throughout one cardiac cycle, systole, and diastole. MAP is influenced by cardiac output and systemic vascular resistance, each of which is influenced by several variables. A common method used to estimate the MAP is the following formula: MAP = DP + 1/3(SP - DP)

    Baseline (assessment), and at 12 weeks post-intervention.

Study Arms (2)

Group A (aerobic exercise with BFR group)

EXPERIMENTAL

Thirty patients will apply moderate aerobic exercise with RBF in form of a treadmill for 30 minutes for 12 weeks (3 sessions/ week).

Other: Aerobic exercise with BFROther: Aerobic training

Group B (aerobic training group)

ACTIVE COMPARATOR

Thirty patients will apply moderate intensity aerobic exercise without BFR for 30 minutes for 12 weeks (3 sessions/ weak).

Other: Aerobic training

Interventions

To prescribe BFR training, Systolic blood pressure (SBP) will be measured using an automated oscillometer BP device. Blood pressure will be measured according to the recommendations of the American Heart Association. A bilateral restriction of 50% of the measured SBP will be applied to each lower limb for the application of BFR of lower limbs using the equipment. A wide cuff (18 cm wide) will be placed in the proximal portion of the thigh (inguinal fold region) and will be inflated until the absence of the tibial artery blood pulse. Thus, a 50% restriction of SBP will be applied in both legs during lower body exercises.

Group A (aerobic exercise with BFR group)

HR max = 206.9 - (0.67 x age). Moderate intensity aerobic exercise: the rate of heart reaches 64-76 percent of their age predicted peak hearty rate

Group A (aerobic exercise with BFR group)Group B (aerobic training group)

Eligibility Criteria

Age60 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • sixty elderly patients.
  • Their ages will range from 60 to 70 years old.
  • Grade II Hypertensive patients (SBP 160-179 mmHg and/or DBP 100-109 mmHg)
  • Patients with dyslipidemia: at least one of the fasting lipid profile tests include the following results.
  • A-Total Cholestrol more than 240 (mg/dl). B-LDL Cholestrol more than 160 (mg/dl). C-HDL Cholestrol less than 40 (mg/dl). D-Triglycerides more than 200 (mg/dl).
  • 'Body Mass Index: from 30: 40 kg/m2 calss I and II obesity.

You may not qualify if:

  • Severe Chest diseases (either obstructive or restrictive).
  • Clinical signs of a severe cardiac event. (eg, severe atherosclerosis, congestive heart failure),
  • Severe psychiatric or cognitive impairment, who unable to follow comment.
  • Neurological disorders affecting respiratory muscles or any muscular dystrophies (cervical disc or bulge).
  • Patients with severe self-limiting illness (e.g., cancer).
  • Peripheral artery disease in lower extremities.
  • Systolic blood pressure \< 180 mmHg, diastolic blood pressure more than 110 mmHg, or resting heart rate above 120 bpm.
  • Patient with uncontrolled - diabetes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Cairo University

Giza, Giza Governorate, 11432, Egypt

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Zeinab Mohamed Helmy, Professor of Physical Therapy

    Professor of Physical Therapy for Cardiovascular / Respiratory Disorders and Geriatrics Faculty of Physical Therapy Cairo University

    STUDY CHAIR
  • Ebtesam Nabil Abdel Mohsen, Lecturer of Physical Therapy

    Lecturer of Physical Therapy for Cardiovascular / Respiratory Disorders and Geriatrics Faculty of Physical Therapy Cairo University

    STUDY DIRECTOR
  • Yasser Abdel Monem Elhendy, Professor of Internal Medicine

    Professor of Internal Medicine Faculty of Medicine Zagazig University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

March 2, 2025

First Posted

March 14, 2025

Study Start

January 1, 2024

Primary Completion

December 1, 2024

Study Completion

February 10, 2025

Last Updated

March 14, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations